These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34339231)

  • 1. Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial.
    Sheldon R; Faris P; Tang A; Ayala-Paredes F; Guzman J; Marquez M; Morillo CA; Krahn AD; Kus T; Ritchie D; Safdar S; Maxey C; Raj SR;
    Ann Intern Med; 2021 Oct; 174(10):1349-1356. PubMed ID: 34339231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the prevention of syncope trial IV: assessment of midodrine.
    Raj SR; Faris PD; McRae M; Sheldon RS
    Clin Auton Res; 2012 Dec; 22(6):275-80. PubMed ID: 22610268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
    Kaufmann H; Saadia D; Voustianiouk A
    Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.
    Qingyou Z; Junbao D; Chaoshu T
    J Pediatr; 2006 Dec; 149(6):777-80. PubMed ID: 17137891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).
    Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W
    Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A
    Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine: a role in the management of neurocardiogenic syncope.
    Ward CR; Gray JC; Gilroy JJ; Kenny RA
    Heart; 1998 Jan; 79(1):45-9. PubMed ID: 9505918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine treatment in children with recurrent vasovagal syncope.
    Bagrul D; Ece I; Yılmaz A; Atik F; Kavurt AV
    Cardiol Young; 2021 May; 31(5):817-821. PubMed ID: 33407967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary for Patients: Midodrine to Prevent Fainting.
    Ann Intern Med; 2021 Oct; 174(10):I28. PubMed ID: 34339224
    [No Abstract]   [Full Text] [Related]  

  • 11. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
    Connolly SJ; Sheldon R; Thorpe KE; Roberts RS; Ellenbogen KA; Wilkoff BL; Morillo C; Gent M;
    JAMA; 2003 May; 289(17):2224-9. PubMed ID: 12734133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.
    Sheldon R; Raj SR; Rose MS; Morillo CA; Krahn AD; Medina E; Talajic M; Kus T; Seifer CM; Lelonek M; Klingenheben T; Parkash R; Ritchie D; McRae M;
    J Am Coll Cardiol; 2016 Jul; 68(1):1-9. PubMed ID: 27364043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient treated with tilt training and midodrine after 68 seconds asystole during head-up tilt table testing.
    Oz F; Cizgici Y; Bilge AK
    Acta Cardiol; 2011 Aug; 66(4):523-5. PubMed ID: 21894812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of midodrin treatment of vasovagal syncope].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2004; 76(8):38-41. PubMed ID: 15471395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
    Smith W; Wan H; Much D; Robinson AG; Martin P
    Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
    Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
    J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
    Aminorroaya A; Tavolinejad H; Sadeghian S; Jalali A; Alaeddini F; Emkanjoo Z; Mollazadeh R; Bozorgi A; Oraii S; Kiarsi M; Shahabi J; Akbarzadeh MA; Rahimi B; Joharimoghadam A; Mohsenizade A; Mohammadi R; Oraii A; Ariannejad H; Apakuppakul S; Ngarmukos T; Tajdini M
    Am Heart J; 2021 Jul; 237():5-12. PubMed ID: 33689731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic prevention of recurrent vasovagal syncope: A systematic review and network meta-analysis of randomized controlled trials.
    Behnoush AH; Yazdani K; Khalaji A; Tavolinejad H; Aminorroaya A; Jalali A; Tajdini M
    Heart Rhythm; 2023 Mar; 20(3):448-460. PubMed ID: 36509319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.
    Mizuguchi Y; Ishimoto T; Kageyama N; Oishi Y; Emi S; Nagase N; Oki T
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):405-8. PubMed ID: 15717144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope].
    Liu XY; Wang C; Wu LJ; Hu CY; Lin P; Li MX; Cui XL; Xie ZW
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1951-4. PubMed ID: 19950567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.